candesartan has been researched along with trichlormethiazide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Kato, T; Mori, T; Nako, K; Ogawa, S; Takeuchi, K | 1 |
| Fukuda, N; Kobayashi, N; Matsumoto, K; Matsumoto, T; Suzuki, R; Tahira, Y; Ueno, T; Yao, EH; Yu, Y | 1 |
1 trial(s) available for candesartan and trichlormethiazide
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Diabetic Nephropathies; Female; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Single-Blind Method; Tetrazoles; Trichlormethiazide; Valine; Valsartan | 2006 |
1 other study(ies) available for candesartan and trichlormethiazide
| Article | Year |
|---|---|
Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antioxidants; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclic N-Oxides; Disease Models, Animal; Diuretics; Endothelial Cells; Hypertension; Male; Myocardium; NADPH Oxidases; Oxidative Stress; Proto-Oncogene Proteins c-kit; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary; Spin Labels; Stem Cells; Tetrazoles; Thiobarbituric Acid Reactive Substances; Trichlormethiazide; Vascular Endothelial Growth Factor A | 2008 |